 | | PATHWAY: cser01100 | |
| Entry |
|
| Name |
Metabolic pathways - Comamonas serinivorans |
| Class |
|
| Pathway map |

|
| Module |
| cser_M00007 | Pentose phosphate pathway, non-oxidative phase, fructose-6P => ribose-5P [PATH:cser01100] |
| cser_M00019 | Valine/isoleucine biosynthesis, pyruvate => valine / 2-oxobutanoate => isoleucine [PATH:cser01100] |
| cser_M00024 | Phenylalanine biosynthesis, chorismate => phenylpyruvate => phenylalanine [PATH:cser01100] |
| cser_M00053 | Deoxyribonucleotide biosynthesis, ADP/GDP/CDP/UDP => dATP/dGTP/dCTP/dUTP [PATH:cser01100] |
| cser_M00125 | Riboflavin biosynthesis, plants and bacteria, GTP => riboflavin/FMN/FAD [PATH:cser01100] |
| cser_M00551 | Benzoate degradation, benzoate => catechol / methylbenzoate => methylcatechol [PATH:cser01100] |
|
| Organism |
Comamonas serinivorans [GN: cser]
|
Related pathway |
| cser00040 | Pentose and glucuronate interconversions |
| cser00130 | Ubiquinone and other terpenoid-quinone biosynthesis |
| cser00250 | Alanine, aspartate and glutamate metabolism |
| cser00260 | Glycine, serine and threonine metabolism |
| cser00280 | Valine, leucine and isoleucine degradation |
| cser00290 | Valine, leucine and isoleucine biosynthesis |
| cser00361 | Chlorocyclohexane and chlorobenzene degradation |
| cser00400 | Phenylalanine, tyrosine and tryptophan biosynthesis |
| cser00520 | Amino sugar and nucleotide sugar metabolism |
| cser00525 | Acarbose and validamycin biosynthesis |
| cser00541 | Biosynthesis of various nucleotide sugars |
| cser00625 | Chloroalkane and chloroalkene degradation |
| cser00630 | Glyoxylate and dicarboxylate metabolism |
| cser00660 | C5-Branched dibasic acid metabolism |
| cser00760 | Nicotinate and nicotinamide metabolism |
| cser00907 | Pinene, camphor and geraniol degradation |
| cser00999 | Biosynthesis of various plant secondary metabolites |
| cser01040 | Biosynthesis of unsaturated fatty acids |
| cser01053 | Biosynthesis of siderophore group nonribosomal peptides |
| cser01055 | Biosynthesis of vancomycin group antibiotics |
|
| KO pathway |
|
|
|